SCHEMBL21929008

SCHEMBL21929008

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1cncc(-n2c3ccc(C)cc3c3cc(C)ccc32)c1-c1cccc(C#N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.40
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
CLK4 Q9HAZ1 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA4 P43681 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.37
F11 P03951 1/20 0.37
BRAF P15056 1/20 0.36
ELANE P08246 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21929011 0.95 IDO1 (0.37) IDO1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL21928374 0.92 CYP1A2 (0.40) IDO1KDM4ECYP1A2CYP3A4CLK4
SCHEMBL21928407 0.92 CYP1A2 (0.42) IDO1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL23098062 0.91 IDO1 (0.39) IDO1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL21929074 0.90 MAT2A (0.43) IDO1KDM4ECYP1A2
SCHEMBL21929211 0.90 IDO1 (0.43) IDO1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL21929014 0.90 IDO1 (0.36) IDO1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL24737201 0.89 CYP1A2 (0.38) IDO1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL21546696 0.88 CLK4 (0.38) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL21928417 0.88 MAP4K4 (0.44) IDO1CYP1A2CYP3A4CLK4CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 US disclosed
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 IDO1 602/4885KDM4E 1828/4885CYP1A2 353/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA IDO1 1840/4885KDM4E 4010/4885CYP1A2 24/4885
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 IDO1 1285/4885KDM4E 4409/4885CYP1A2 134/4885
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 IDO1 1285/4885KDM4E 4409/4885CYP1A2 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.